Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T79747 | Target Info | |||
Target Name | Protein-serine O-palmitoleoyltransferase porcupine (PORCN) | ||||
Synonyms | Protein-cysteine N-palmitoyltransferase porcupine; Protein MG61; PORCN | ||||
Target Type | Clinical trial Target | ||||
Gene Name | PORCN | ||||
Biochemical Class | Acyltransferase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Digitonin | Ligand Info | |||
Canonical SMILES | CC1CCC2(C(C3C(O2)C(C4C3(CCC5C4CCC6C5(CC(C(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)CO)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O)C)C)O)C)OC1 | ||||
InChI | 1S/C56H92O29/c1-19-7-10-56(75-17-19)20(2)31-45(85-56)37(67)32-22-6-5-21-11-26(24(61)12-55(21,4)23(22)8-9-54(31,32)3)76-50-42(72)39(69)44(30(16-60)80-50)81-53-48(47(36(66)29(15-59)79-53)83-49-40(70)33(63)25(62)18-74-49)84-52-43(73)46(35(65)28(14-58)78-52)82-51-41(71)38(68)34(64)27(13-57)77-51/h19-53,57-73H,5-18H2,1-4H3/t19-,20+,21+,22-,23+,24-,25-,26-,27-,28-,29-,30-,31+,32-,33+,34-,35+,36-,37+,38+,39-,40-,41-,42-,43-,44+,45-,46+,47+,48-,49+,50-,51+,52+,53+,54-,55+,56-/m1/s1 | ||||
InChIKey | UVYVLBIGDKGWPX-KUAJCENISA-N | ||||
PubChem Compound ID | 6474107 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7URD Human PORCN in complex with LGK974 and WNT3A peptide | ||||||
Method | Electron microscopy | Resolution | 2.92 Å | Mutation | No | [1] |
PDB Sequence |
FSRQEFFQQL
13 LQGCLLPTAQ23 QGLDQIWLLL33 AICLACRLLW43 RLGLPSYLKH53 ASTVAGGFFS 63 LYHFFQLHMV73 WVVLLSLLCY83 LVLFLCRHSS93 HRGVFLSVTI103 LIYLLMGEMH 113 MVDTVTWHKM123 RGAQMIVAMK133 AVSLGFDLDR143 GEVGTVPSPV153 EFMGYLYFVG 163 TIVFGPWISF173 HSYLQAVQGR183 PLSCRWLQKV193 ARSLALALLC203 LVLSTCVGPY 213 LFPYFIPLNA234 RWLRAYESAV244 SFHFSNYFVG254 FLSEATATLA264 GAGFTEEKDH 274 LEWDLTVSKP284 LNVELPRSMV294 EVVTSWNLPM304 SYWLNNYVFK314 NALRLGTFSA 324 VLVTYAASAL334 LHGFSFHLAA344 VLLSLAFITY354 VEHVLRKRLA364 RILSACVLSK 374 RCPPDCSHQH384 RLGLGVRALN394 LLFGALAIFH404 LAYLGSLFDV414 YGMAYTVHKW 434 SELSWASHWV444 TFGCWIFYRL454 IG
|
|||||
|
||||||
PDB ID: 7URA Human PORCN in complex with Palmitoleoyl-CoA | ||||||
Method | Electron microscopy | Resolution | 3.11 Å | Mutation | No | [1] |
PDB Sequence |
FSRQEFFQQL
13 LQGCLLPTAQ23 QGLDQIWLLL33 AICLACRLLW43 RLGLPSYLKH53 ASTVAGGFFS 63 LYHFFQLHMV73 WVVLLSLLCY83 LVLFLCRHSS93 HRGVFLSVTI103 LIYLLMGEMH 113 MVDTVTWHKM123 RGAQMIVAMK133 AVSLGFDLDR143 GEVGTVPSPV153 EFMGYLYFVG 163 TIVFGPWISF173 HSYLQAVQGR183 PLSCRWLQKV193 ARSLALALLC203 LVLSTCVGPY 213 LFPYFIPLNA234 RWLRAYESAV244 SFHFSNYFVG254 FLSEATATLA264 GAGFTEEKDH 274 LEWDLTVSKP284 LNVELPRSMV294 EVVTSWNLPM304 SYWLNNYVFK314 NALRLGTFSA 324 VLVTYAASAL334 LHGFSFHLAA344 VLLSLAFITY354 VEHVLRKRLA364 RILSACVLSK 374 RCPPDCSHQH384 RLGLGVRALN394 LLFGALAIFH404 LAYLGSLFDV414 YGMAYTVHKW 434 SELSWASHWV444 TFGCWIFYRL454 IG
|
|||||
|
||||||
PDB ID: 7URC Human PORCN in complex with LGK974 | ||||||
Method | Electron microscopy | Resolution | 3.14 Å | Mutation | No | [1] |
PDB Sequence |
FSRQEFFQQL
13 LQGCLLPTAQ23 QGLDQIWLLL33 AICLACRLLW43 RLGLPSYLKH53 ASTVAGGFFS 63 LYHFFQLHMV73 WVVLLSLLCY83 LVLFLCRHSS93 HRGVFLSVTI103 LIYLLMGEMH 113 MVDTVTWHKM123 RGAQMIVAMK133 AVSLGFDLDR143 GEVGTVPSPV153 EFMGYLYFVG 163 TIVFGPWISF173 HSYLQAVQGR183 PLSCRWLQKV193 ARSLALALLC203 LVLSTCVGPY 213 LFPYFIPLNA234 RWLRAYESAV244 SFHFSNYFVG254 FLSEATATLA264 GAGFTEEKDH 274 LEWDLTVSKP284 LNVELPRSMV294 EVVTSWNLPM304 SYWLNNYVFK314 NALRLGTFSA 324 VLVTYAASAL334 LHGFSFHLAA344 VLLSLAFITY354 VEHVLRKRLA364 RILSACVLSK 374 RCPPDCSHQH384 RLGLGVRALN394 LLFGALAIFH404 LAYLGSLFDV414 YGMAYTVHKW 434 SELSWASHWV444 TFGCWIFYRL454 IG
|
|||||
|
||||||
PDB ID: 7URE Human PORCN in complex with palmitoleoylated WNT3A peptide | ||||||
Method | Electron microscopy | Resolution | 3.19 Å | Mutation | No | [1] |
PDB Sequence |
FSRQEFFQQL
13 LQGCLLPTAQ23 QGLDQIWLLL33 AICLACRLLW43 RLGLPSYLKH53 ASTVAGGFFS 63 LYHFFQLHMV73 WVVLLSLLCY83 LVLFLCRHSS93 HRGVFLSVTI103 LIYLLMGEMH 113 MVDTVTWHKM123 RGAQMIVAMK133 AVSLGFDLDR143 GEVGTVPSPV153 EFMGYLYFVG 163 TIVFGPWISF173 HSYLQAVQGR183 PLSCRWLQKV193 ARSLALALLC203 LVLSTCVGPY 213 LFPYFIPLNA234 RWLRAYESAV244 SFHFSNYFVG254 FLSEATATLA264 GAGFTEEKDH 274 LEWDLTVSKP284 LNVELPRSMV294 EVVTSWNLPM304 SYWLNNYVFK314 NALRLGTFSA 324 VLVTYAASAL334 LHGFSFHLAA344 VLLSLAFITY354 VEHVLRKRLA364 RILSACVLSK 374 RCPPDCSHQH384 RLGLGVRALN394 LLFGALAIFH404 LAYLGSLFDV414 YGMAYTVHKW 434 SELSWASHWV444 TFGCWIFYRL454 IG
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .AJP or .AJP2 or .AJP3 or :3AJP;style chemicals stick;color identity;select .A:96 or .A:97 or .A:100 or .A:101 or .A:103 or .A:104 or .A:107 or .A:135 or .A:139 or .A:307 or .A:312 or .A:315 or .A:316 or .A:318 or .A:319 or .A:331 or .A:334 or .A:335; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Mechanisms and inhibition of Porcupine-mediated Wnt acylation. Nature. 2022 Jul;607(7920):816-822. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.